Assessment of the MEST criteria in childhood HSP nephritis

  • Research type

    Research Study

  • Full title

    ASSESSMENT OF THE OXFORD CLASSIFICATION (MEST CRITERIA) IN IDENTIFYING PATIENTS WITH POOR OUTCOMES FOLLOWING HENOUCH-SCHONLEIN PURPURA IN CHILDHOOD

  • IRAS ID

    202763

  • Contact name

    Andrew Lunn

  • Contact email

    andrew.lunn@nuh.nhs.uk

  • Sponsor organisation

    Nottingham University Hospitals NHS Trust

  • Duration of Study in the UK

    0 years, 6 months, 0 days

  • Research summary

    Henoch-Schonlein Purpura (HSP) is a condition in which the immune system reacts against the body’s own small blood vessels. It can occur at any age but commonly affects children. It typically affects small blood vessels in the skin (causing a typical purple rash), the joints, the bowel and the kidney. In most children it improves without specific treatment but in some children there are long term consequences mainly related to how active the inflammation is within the kidneys.

    In children who are severely affected a renal biopsy is done. This is when a small amount of tissue is taken from the kidney and studied under a microscope. Children who have more severe grades of inflammation are then treated with medicine to reduce the inflammation.

    Traditionally, the International Study of Kidney Disease in Children (ISKDC) classification is used to grade the amount of inflammation seen when the kidney is studied under the microscope. Research studies have not consistently been able to show that children with the more severe grades of inflammation when using the ISKDC have more severe long term outcomes and therefore need more treatment.

    An alternative method for grading inflammation and damage in renal biopsies is the Oxford Classification or MEST criteria. Our study will assess the effectiveness of the MEST criteria in predicting long term outcomes of patients with HSP nephritis in Nottingham. This study will then compare the usefulness of the MEST criteria and the ISKDC classification in predicting long term outcomes of patients with HSP nephritis.

  • REC name

    East Midlands - Leicester South Research Ethics Committee

  • REC reference

    16/EM/0419

  • Date of REC Opinion

    4 Oct 2016

  • REC opinion

    Further Information Favourable Opinion